30th March 2021
- 0 comments
A University of Nottingham spin-out which has developed a rapid test that could be a ‘game changer’ in combatting tuberculosis (TB) in livestock has secured a £2.3m investment to help bring its product to market. The funding for PBD Biotech has come from a consortium led by fund managers Mercia and the Foresight Group, which were both investing through the Midlands Engine Investment Fund (MEIF); the University of Nottingham; the government’s Future Fund; and private investors including farmers and veterinary practices.
...In order to read the full story we need you to be registered with us, please click the links below to login or register.